Wordt geladen...
Diabetes and Cardiovascular Risk: Are Dipeptidyl Peptidase-4 Inhibitors Beneficial?
Cardiovascular (CV) disease is a major cause of morbidity and mortality in patients with diabetes. Whereas the link between glycemic control and reducing microvascular disease is firmly established, the evidence for macrovascular risk reduction remains unclear. Despite a host of available drugs for...
Bewaard in:
| Gepubliceerd in: | Hosp Pharm |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Thomas Land Publishers, Inc.
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4252196/ https://ncbi.nlm.nih.gov/pubmed/25477593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj4908-697 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|